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a  b  s  t  r  a  c  t
Hepatitis  E virus  (HEV)  is a fecal-orally  transmitted  member  of the  genus  Hepevirus  that
causes acute  hepatitis  in humans  and  is widely  distributed  throughout  the  world.  Pigs
have been  reported  as  the  main  source  of  genotypes  3 and  4  infection  to  humans  in non-
endemic  areas.  To  investigate  HEV  infection  in pigs  from  different  regions  of  Pará  state
(Eastern  Brazilian  Amazon),  we performed  serological  and  molecular  analyses  of serum,
fecal  and  liver  samples  from  151  adult  pigs  slaughtered  between  April  and  October  2010  in
slaughterhouses  in  the metropolitan  region  of  Belém,  Pará.  Among  the animals  tested,  8.6%
(13/151)  were  positive  for anti-HEV  IgG  but not  for anti-HEV  IgM.  HEV  RNA  was  detected
in 4.8%  (22/453)  of  the  samples  analyzed  and  9.9%  (15/151)  of  the animals  had  at  least  one
positive sample.  Phylogenetic  analysis  showed  that all  sequences  belonged  to  genotype  3
that  were  related  to human  isolates  from  other non-endemic  regions,  suggesting  that  the
isolates had  zoonotic  potential.  Subtypes  3c  and  3f were  simultaneously  detected  in  some
pigs, suggesting  co-infection  by more  than  one  strain  and/or  the presence  of a recombinant
virus.  These  results  constitute  the  ﬁrst  molecular  and  serologic  evidence  of swine  HEV
circulation  in  the  Eastern  Brazilian  Amazon.
© 2012 Elsevier Ltd. All rights reserved.
1. Introduction
Hepatitis E virus (HEV) is an RNA virus of the genus
Hepevirus that causes acute hepatitis in humans and is
 The GenBank/EMBL/DDBJ accession numbers for the sequences
described in this study are JN983199–JN983212 (ORF1) and
JN983192–JN983198 ORF2.
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Barroso, 492, 66093-020 Belém, PA, Brazil. Tel.: +55 91 3214 2072;
fax: +55 91 3214 2139.
E-mail address: souzajralex@hotmail.com (A.J.S. de Souza).
transmitted through fecal-oral route [1]. In mammals, HEV
strains have been classiﬁed into four genotypes (1–4) based
on their genetic diversity; additionally, subtypes have been
identiﬁed within each genotype group and among them
genotype 3 shows the highest variability [2].
These genotypes show a characteristic geographic dis-
tribution: genotype 1 is considered endemic in Asia and
northern Africa; outbreaks of genotype 2 have been
reported in Mexico and central Africa; genotype 3 is found
in North and South America, parts of Europe and Japan; and
genotype 4 has been reported in China, Japan, Taiwan and
Vietnam [3].
0147-9571/$ – see front matter ©  2012 Elsevier Ltd. All rights reserved.
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Genotypes 1 and 2 are epidemic, infecting only humans
and exhibiting low genetic diversity (ﬁve and two  subtypes,
respectively) compared with genotypes 3 and 4 (ten and
seven subtypes, respectively).
Genotypes 3 and 4 are described as zoonotic because
they are found in areas where human and animal isolates of
HEV shows strong genetic similarities [3].  Meng et al. were
the ﬁrst to identify swine HEV and phylogenetic analysis
revealed that it was highly similar to human HEV isolate,
suggesting a probable zoonotic infection [4].
Domestic pigs are reported to be the main source of
genotypes 3 and 4 infection in humans living in non-
endemic regions [5,6], but HEV has also been identiﬁed in
wild boar [7,8], deer [7],  mongoose [9],  rats [10], rabbits
[11], and there is also a similar avian virus [12,13].
In Brazil, swine HEV was isolated for the ﬁrst time from
fecal samples of pigs from the São Paulo state, in South-
eastern Brazil. A phylogenetic analysis of these samples
demonstrated similarities with genotype 3 [14]. HEV geno-
type 3 infections were also found in pigs and efﬂuents
from a pig slaughterhouse in Rio de Janeiro state, located
at Southeastern Brazil [15,16].
Recently, the ﬁrst human case of autochthonous hepati-
tis E in Brazil was identiﬁed in a patient with acute non-A–C
hepatitis. The virus infecting this patient was identiﬁed as
HEV genotype 3b, which indicated that the origin of the
infection was probably zoonotic [16].
Studies on the occurrence of HEV infection in swine are
still scarce in Brazil. Due to the zoonotic features of this
infection, further studies on HEV epidemiology are needed.
Therefore, the aim of this study was to investigate the
prevalence of HEV infection in pigs at slaughterhouses in
Pará state, Eastern Brazilian Amazon and to characterize
the genotypes circulating in this region.
2. Material and methods
2.1. Samples
From April to October 2010, serum, feces and liver
samples were collected from 151 slaughtered pigs (approx-
imately six months old) from different regions of Pará state,
Brazil. The samples were collected from 95 animals from
the municipality of Bujarú slaughtered in an ofﬁcially reg-
istered slaughterhouse located in the municipality of Santa
Isabel do Pará. This slaughterhouse operates according to
the sanitary inspection criteria established by the Agri-
cultural Protection Agency of the state of Pará, which are
mainly based on the visual inspection of the viscera and
carcasses prior to the approval of the slaughter products
for sale.
The samples from other 56 animals were collected at
three illegal slaughterhouses in the municipality of Belém.
These establishments were not legally registered with the
ofﬁcial health regulatory agencies for this type of activity,
and they typically slaughter animals from small-scale fam-
ily farms for the direct sale of the slaughter products in
open-air markets and stores in the city. These 56 animals
were from the municipalities of Belém, Marituba, Santa
Isabel do Pará, Castanhal and the Marajó Archipelago.
Serum, liver and feces samples were collected during
the slaughter of each animal, and all the biological material
was  frozen at −70 ◦C until further analysis.
This study was  approval by the Ethics Com-
mittee for Animal Research of the Evandro
Chagas Institute Belém/Pará/Brazil (Approval No.
0019/2010/CEPAN/IEC/SVS/MS), and the procedures
involved met  all ethical and animal welfare requirements
of this committee.
2.2. Serological detection
The presence of anti-HEV IgM and IgG were analyzed
in all serum samples using the commercial indirect ELISA
kit RecomWell HEV IgM and IgG (Mikrogen, Neuried,
Germany) according to the manufacturer’s instructions.
Brieﬂy, 10 L serum samples were diluted in 1 mL  buffer
solution and 100 L of this dilution, positive, negative and
cutoff controls were applied to wells coated with ORF2 and
ORF3 HEV proteins, incubated for 1 h at room tempera-
ture, washed four times (300 L per well), incubated again
with 100 L anti-human peroxidase conjugate, washed,
and incubated with 100 L substrate solution. Absorbance
values were measured with an automatic microplate
reader (450 nm/650 nm)  immediately after reaction block-
ing. Background threshold and antibody concentrations
were calculated based on formulas according to the val-
ues of the positive, negative and cutoff controls provided
in the commercial assay.
To conﬁrm serological reactivity, serum samples with
positive or inconclusive results using ELISA were subse-
quently tested with the commercial immunoblotting kit
RecomLine HEV (Mikrogen, Neuried, Germany). Diluted
serum samples were incubated with test strips loaded with
puriﬁed HEV recombinant antigens and a color reaction in
gray scale at the speciﬁc sites in test strips provides positive
result.
In addition to the positive and negative controls sup-
plied with the kits, internal positive controls were added
(positive anti-HEV human and swine serum samples). All
the positive and/or inconclusive samples were tested in
duplicate and the serological tests were also validated
according to the manufacturer’s guidelines.
2.3. RNA extraction
HEV RNA was  extracted from the 250 L serum samples
by the acid guanidinium thiocyanate/phenol/chloroform
method [17] using the TRIzol LS reagent (Invitrogen, CA,
USA) using the manufacturer’s instructions.
Extraction of HEV RNA from the fecal samples was
carried out by using RNeasy mini kits (QIAGEN, Hilden,
Germany): fecal samples were prepared in a 10% solution
diluted in PBS pH 7.4 and after vigorous shaking were incu-
bated at 4 ◦C overnight. Samples were then centrifuged
at 20,000 × g for 5 min  and the supernatant was used to
extraction with RNeasy mini kit according to the manufac-
turer’s recommendations.
Viral RNA was also extracted from the liver samples
using RNeasy mini kits (QIAGEN) following manufacturer’s
instructions.
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2.4. Nested RT-PCR
Reverse transcription for cDNA synthesis was  per-
formed using random primers and the Moloney Murine
Leukemia Virus Reverse Transcriptase (Invitrogen).
We used nested RT-PCR to amplify three regions of the
HEV genome. Initially, two sets of primers that ampliﬁed
fragments of ORF1 and ORF2 genes were used [18].
ORF1 primers were located at nucleotide positions
56–79 and 473–451, which corresponded to the methyl-
transferase coding region. The external primers (Cons-
ORF1-s1: 5′-CTGGCATYACTACTGCYATTGAGC-3′ and
ConsORF1-a1: 5′-CCATCRARRCAGTAAGTGCGGTC-3′) and
internal primers (ConsORF1-s2: 5′-CTGCCYTKGCGAA-
TGCTGTGG-3′ and ConsORF1-a2: 5′-GGCAGWRTACCA-
RCGCTGAACATC-3′) ampliﬁed 418 and 287 bp fragments,
respectively.
ORF2 primers corresponded to positions
6298–6321 and 6494–6470 of the Burmese pro-
totype. The external primers (ConsORF2-s1:
5′-GACAGAATTRATTTCGTCGGCTGG-3′ and ConsORF2-
a1: 5′-CTTGTTCRTGYTGGTTRTCATAATC-3′) ampliﬁed a
197 bp product in the ﬁrst PCR, and the internal primers
(ConsORF2-s2: 5′-GTYGTCTCRGCCAATGGCGAGC-3′ and
ConsORF2-a2: 5′-GTTCRTGYTGGTTRTCATAATCCTG-3′)
ampliﬁed a 145 bp product in the second PCR.
The samples were also tested using a third set of
primers that ampliﬁed an additional ORF2 region. The
external (3156NF: 5′-AATTATGCYCAGTAYCGRGTTG-3′ and
3157NR: 5′-CCCTTRTCYTGCTGMGCATTCTC-3′) and inter-
nal primers (3158NF: 5′-GTWATGCTYTGCATWCATGGCT-
3′ and 3159NR: 5′-AGCCGACGAAATCAATTCTGTC-3′) used
in the present study were described for the detection of
HEV and ampliﬁed 731 and 348 bp products in the ﬁrst and
second PCRs, respectively [19,20].
All precautions and procedures suggested to avoid false
positive results were strictly followed [21]. The extraction
of nucleic acids, the PCR setup and especially the addition
of ﬁrst round PCR reaction to second round PCR were per-
formed in completely separated rooms, when necessary
inside biohazard cabinets or PCR hoods. Each stage was
performed with separate micropipettes and all PCR pro-
cedures were carried out using aerosol ﬁlter tips. Other
precautions such as frequent changing of gloves, working
with reagents divided in aliquot, control of daily ﬂow of
personnel only from pre- to post-ampliﬁcation areas and
the use of UV-light and sodium hypochlorite solution to
decontaminate surfaces were strictly observed in order to
prevent cross-contamination.
Positive control (serum from a pig positive to HEV) to
conﬁrm the effectiveness of the reactions and negative con-
trols (water) to check for contaminants were included in
each run.
PCR reactions had a ﬁnal volume of 50 L and con-
tained the following reagents: 35.3 L DEPC-treated H2O;
5 L 10× PCR buffer; 1 L dNTPs (10 mM)  (Invitrogen);
1.5 L MgCl2 (50 mM)  (Invitrogen); 20 pmol of each primer
(forward and reverse); 1 U of Platinum Taq polymerase
(Invitrogen) and 5 L cDNA sample. In the second PCR,
5 L of the ﬁrst PCR product was added instead of
cDNA.
PCR ampliﬁcation cycles were: initial denaturation at
94 ◦C for 2 min, followed by 35 cycles of denaturation (94 ◦C
for 30 s), annealing (50 ◦C for 30 s), extension (72 ◦C for
30 s) and a ﬁnal extension at 72 ◦C for 5 min. The anneal-
ing temperature differed only for the 348 bp ORF2 primers
(42 ◦C).
The products of the second PCR were labeled with
SYBR dye (Invitrogen) and separated by electrophoresis
on 1% agarose gel. Depending on the primers used, sam-
ples that exhibited sharp, intense bands with approximate
sizes of 145, 287 or 348 base pairs were considered as
positive.
2.5. Nucleotide sequencing and phylogenetic analysis
PCR products (ORF1 287 bp and ORF2 348 bp) from
the second round reaction were puriﬁed using ExoSAP-
IT PCR Clean-up Kit (GE Healthcare) and were then
sequenced using the BigDye® Terminator v3.1 Cycle
Sequencing Kit (Applied Biosystems, CA, USA) according
to the manufacturer’s guidelines. Sequencing was carried
out on an automated ABI 3500 DNA Sequencer (Applied
Biosystems).
The quality of each electropherogram was evaluated
using the Phred-Phrap software [22,23] and consen-
sus sequences of forward and reverse sequences were
obtained using CAP3 software available at the web  page
http://asparagin.cenargen.embrapa.br/phph/.
Sequences were aligned and edited using BioEdit (v.
7.0.8) and the integrated CLUSTAL W program [24]. HEV
genotypes and subtypes were classiﬁed by phylogenetic
reconstructions using published reference sequences from
GenBank database (http://www.ncbi.nlm.nih.gov/).
Bayesian phylogenetic analyses were conducted using
the Markov Chain Monte Carlo (MCMC) simulation
implemented in BEAST v.1.6.1 [25] under uncorrelated
exponential relaxed molecular clock using the model of
nucleotide substitution (GTR + G + I). The maximum clade
credibility (MCC) tree was  obtained from summarizing the
10,000 substitution trees and then it was  removed 10% of
burn-in using Tree Annotator v.1.6.1 [25].
Nucleotide sequence divergence was  calculated using
the program MEGA4 (Molecular Evolutionary Genetics
Analysis) software version 4.0 [26].
3. Results
3.1. Serological detection
Anti-HEV IgG was detected using ELISA (background
threshold = 0.3) in 4.6% (7/151) of the samples (mean
absorbance = 0.643 ± 0.214). In addition, 3.9% (6/151)
of the samples showed inconclusive result (mean
absorbance = 0.308 ± 0.024). The average concentra-
tions of the anti-HEV IgG antibodies were 42.1 ± 14.6 U/mL
for the seven positive samples and 20.5 ± 1.6 U/mL for the
six inconclusive samples. Anti-HEV IgM was not detected
in any of the analyzed samples.
All thirteen samples (8.6%; 13/151) with reactivity
(positive or inconclusive) to anti-HEV IgG showed posi-
tive results in the immunoblotting assay. These positive
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Table  1
Molecular detection of HEV in pigs from the state of Pará using nested RT-PCR.
Pig identiﬁcation Sample type Results of RT-PCR HEV
ORF2 (145 bp) ORF1 (287 bp) ORF2 (348 bp)
#025
Serum − + −
Feces − − −
Liver − − −
#027
Serum + + −
Feces + + +
Liver + + +
#028
Serum − − −
Feces − − −
Liver − + −
#029
Serum  − − −
Feces + + +
Liver − + −
#030
Serum − − −
Feces − + −
Liver  − − −
#031
Serum − − −
Feces − + −
Liver − − −
#032
Serum − − −
Feces − + −
Liver − − −
#034
Serum − − −
Feces − + +
Liver − − −
#035
Serum − + +
Feces − + +
Liver − + −
#036
Serum − − −
Feces −  − −
Liver − + −
#037
Serum −  − −
Feces − + +
Liver −  − −
#080
Serum − − −
Feces − + −
Liver − − −
#125
Serum + − +
Feces + + +
Liver + + +
#147
Serum − − −
Feces − + −
Liver − − −
#150
Serum − − −
Feces + − −
Liver − − −
Positive samples/total examined (%) 8/453 (1.76%) 20/453 (4.41%) 10/453 (2.2%)
samples were collected from different geographical ori-
gins: ten were from the municipality of Bujarú, two  were
from the municipality of Castanhal, and one was from the
Marajó Archipelago.
3.2. HEV RNA detection and sequencing
Nested RT-PCR with three sets of primers was  used
to analyze serum, feces and liver samples (n = 453) from
151 pigs. HEV RNA was  detected in ﬁfteen animals (9.9%;
15/151), which had at least one positive sample by at least
one set of primers.
Among 453 samples analyzed, HEV RNA was detected in
4.8% (22/453) with at least one set of primers. Feces were
the samples where HEV RNA was more frequently detected
(12/22), followed by liver (6/22) and serum (4/22).
HEV RNA was ampliﬁed using all the three sets of
primers only in ﬁve samples and the primers generating the
287 bp product showed the highest sensibility to HEV RNA
detection. The 287 bp ORF1 fragment were ampliﬁed in 20
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(4.4%) samples (three serum, eleven feces and six liver); the
145 bp ORF2 fragment in eight (1.7%) samples (two serum,
four feces and two liver) and the 348 bp ORF2 fragment was
ampliﬁed in ten (2.2%) samples (two serum, six feces and
two liver).
Only three pigs had HEV RNA detectable in all samples
analyzed (serum, liver and feces); in two pigs HEV RNA was
detected only in liver samples; viremia was present in four
pigs and twelve were shedding virus in feces (Table 1).
HEV RNA positive pigs were from different origins:
twelve were from the municipality of Bujarú, two were
from Castanhal and one was from Marajó.
Only one pig (#027) with serological evidence of HEV
infection (anti-HEV IgG positive) had HEV RNA detectable
(7.7%; 1/13), which was ampliﬁed in its three samples.
All ampliﬁed samples were sequenced but only
sequences from ORF1 (287 bp) and ORF2 (348 bp) were
used for genotype/subtype classiﬁcation by phyloge-
netic analysis. Due to the short length (145 bp) of the
other ORF2 ampliﬁed fragment, these sequences were
not used to this analysis, they were only submitted for
analysis in BLAST (Basic Local Alignment Search Tool,
http://www.ncbi.nlm.nih.gov/BLAST) to conﬁrm similarity
with HEV.
Sequences with good quality were obtained from ﬁf-
teen samples of the ORF1 (287 bp) and from seven of the
ORF2 (348 bp), that were selected and after used for geno-
type/subtype characterization.
3.3. Phylogenetic analysis
The phylogenetic analyses of ﬁfteen sequences from the
ORF1 5′-terminal region shows that all isolates grouped
with HEV genotype 3 reference sequences. Among these,
fourteen were much more closely related with subtype
3c, whereas the other sequence (#035) grouped with
sequences of subtype 3f (Fig. 1). A calculation of the diver-
gence among the ﬁfteen ORF1 sequences indicated that
they had a nucleotide identity ranging from 78% to 100%.
The topology of phylogenetic tree based on the ORF2 5′-
terminal sequences also showed that only HEV genotype 3
circulated among infected pigs from Pará state (Fig. 2). In
this analysis, three sequences grouped with subtype 3c and
the other four with subtype 3f. These seven samples had a
nucleotide identity ranging from 93% to 100%.
Two pigs (#034 and #035) showed different subtypes
in the same sample (feces): for these cases, when ORF1
sequence was analyzed the strain was classiﬁed as subtype
3c and based on results of the ORF2 sequence analysis, the
samples were classiﬁed as subtype 3f (Figs. 1 and 2). The
pig #035 also showed different subtypes in different sam-
ples analyzed: ORF1 sequences of the strain isolated from
feces and liver samples were classiﬁed as 3c, but the ORF1
sequence of the strain isolated from serum sample was 3f
(Fig. 1). Table 2 summarizes these ﬁndings.
4. Discussion
In this study, we showed that HEV is circulating among
pigs from different areas of the Pará state, located in East-
ern Brazilian Amazon, North region of the country. We
Table 2
Divergent HEV subtypes found in samples from pigs in the state of Pará.
Animal # Sample HEV subtypes identiﬁed by
phylogenetic analysis
ORF1 ORF2
#034 Feces 3c 3f
#035 Serum 3f 3f
Feces 3c 3f
Liver 3c ND
ND = not determined.
found that among pigs from this region 9.9% (15/151)
were currently infected with HEV (HEV RNA positive);
these ﬁndings conﬁrm the circulation of HEV among pigs
in Brazil, where pigs with HEV infection also has been
reported in other three different regions of the country
[14,15,27].
The prevalence of anti-HEV IgG found among pigs from
Pará state was  lower (8.6%; 13/151) than that previously
reported among pigs from other Brazilian regions: in pigs
from Mato Grosso state a high (81.2%) seroprevalence of
anti-HEV IgG was found [28], whereas in the Rio de Janeiro
state, at southeastern region, the seroprevalence was 24.3%
[29]. Differences in prevalence of serological markers of
HEV infection (anti-HEV IgG/IgM) around the world have
been related to speciﬁcity and sensibility of the commer-
cially available serological assays and this may  explain
the differences seen in HEV seroprevalence results among
pigs from different regions of Brazil [30]. Moreover, some
studies have been show that HEV prevalence is directly
associated with differences in the hygiene and sanitary
management of the rearing facilities [31,32].
Likewise, the failure to detect anti-HEV IgM in the
present study may  also be related to the sensitivity and
speciﬁcity of the test used for the serological diagnosis
[33], but can also be due to the brief period while this
immunoglobulin is detected during the infection cycle [34].
Anti-HEV IgM antibody levels appear to be age-dependent,
with the highest proportion found in young pigs (up to
three months old) in response to their ﬁrst contact with the
virus, which usually occurs soon after weaning [20,35–38].
The samples analyzed in the present study were obtained
from pigs at slaughter age (approximately six months),
what may  have led to the failure in detecting IgM antibod-
ies.
Interestingly, in the present study, HEV RNA was more
frequently detected among pigs without serological evi-
dence of HEV infection: among ﬁfteen pigs with positive
PCR, only one (pig #027) had detectable anti-HEV IgG.
In this pig, anti-HEV IgG was detected at low levels
(25.6 U/mL) and HEV RNA was  detected in its serum, feces
and liver samples. Considering the possibility that the virus
can be maintained among infected populations, this animal
may  represents a case of re-infection [37].
Twelve (7.9%; 12/151) seropositive animals in which
HEV RNA was  not detected appear to represent cases of
previous infection. Although HEV infection may  occur in
any age, it has been reported that it occurred more fre-
quently among pigs aging from 3 to 4 months and when
most of these animal reach slaughter age, they had already
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Fig. 1. Maximum clade credibility (MCC) tree estimated by Bayesian analysis of HEV sequences from the 5′ terminal region of ORF1 (266 nt). Sequences
characterized in this study (n = 15) are highlighted in red and sequences obtained from GenBank (n = 75) are identiﬁed by their accession number followed
by  the source, geographic origin and genotype/subtype of the isolated virus. The collapsed clades correspond to sequences of HEV genotypes 1 and 3. The
values  of posterior probability are shown above their respective key nodes.
developed anti-HEV and the presence of the virus is not
detected in blood, liver or fecal samples [39].
Fourteen pigs were found with a positive PCR in the
absence of HEV serum antibodies. HEV replication with-
out serological evidence of HEV infection in pigs has been
related to recent infection when HEV RNA was detected in
liver or bile. On the other hand, when it was detected only
in stools, it was suggested a possible transient intestinal
presence of the virus without replication after ingestion
[35]. This pattern was found in eight pigs in this study.
Among seronegative pigs, HEV RNA was more frequently
detected in fecal samples, followed by liver and serum.
The pigs that had HEV RNA detectable only in feces may
be cases of transient intestinal presence of the virus. Nev-
ertheless, it is reasonable to consider that HEV antibodies
were in low levels and the serological assay used was not
sensitive enough for their detection. In fact, a recent study
reported low levels of ELISA optical density values for anti-
HEV IgG among most of the studied pigs, independently of
the life cycle period evaluated: 2, 8, 18 or 22–29 weeks [20].
These authors also reported that in all sampling, especially
at the third (18 weeks) and ﬁnal sampling (slaughter), HEV
RNA was more frequently detected in feces than in serum
[20]. This ﬁnding agrees with the knowledge that fecal virus
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Fig. 2. Maximum clade credibility (MCC) tree estimated by Bayesian analysis of HEV sequences from the 5′ terminal region of ORF2 (346 nt). Sequences
characterized in this study (n = 7) are highlighted in red and sequences obtained from GenBank (n = 94) are identiﬁed by their accession number followed
by  the source, geographic origin and genotype/subtype of the isolated virus. The collapsed clades correspond to sequences of HEV genotypes 1 and 3. The
values  of posterior probability are shown above their respective key nodes.
shedding may  persist longer than viremia [5,34].  Moreover,
several studies had reported that detection of HEV RNA in
the liver samples was less frequent than in feces or bile [5].
The latter is the sample where HEV RNA has been found
more frequently [35,40]. It is possible that in the present
study seronegative animals with positive PCR only in feces
had also HEV RNA detectable in their bile, but we cannot
conﬁrm this because it was not collected.
Seronegative pigs with positive PCR may  represent
cases of HEV re-infection, although in some cases a more
prolonged infection might have occurred, as suggested by
other authors [31].
HEV strains characterized in this study were classiﬁed
as genotype 3, the genotype that was also reported from
pigs and humans living in countries with sporadic cases of
HEV infection [1,4,18,41–50].  HEV genotype 3 was also pre-
viously described in Brazil infecting pigs from other regions
of  the country [14,15,27] and involved in a human infection
case [16].
A phylogenetic analysis of ﬁfteen HEV ORF1 sequences
indicated that fourteen strains belonged to subtype 3c
and one sequence belonged to subtype 3f. This subtype 3f
sequence was  obtained from a strain isolated from serum
sample of pig #035 and exhibited 22% nucleotide diver-
gence from the other ORF1 sequences from the strains
isolated from feces and liver samples obtained of the same
animal. This result suggests the occurrence of co-infection
by more than one subtype of the virus in a single animal,
with one strain circulating in the blood stream and the
other constrained to the liver and gastrointestinal system.
This result is probably due the presence of multiple HEV
variants circulating in the farm.
HEV subtypes 3c and 3f have also been identiﬁed
conjointly in slaughtered pigs from Italy, however, the
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sequences obtained from multiple samples taken from the
same animal were identical, i.e., they did not group into
different subtypes [35], as was found in pig #035 case.
Although they did not detect cases of co-infection with
multiple viral subtypes, the aforementioned authors did
not rule out this possibility. Coexistence of more than
one swine HEV subtype from the same genotype circulat-
ing in the environment appears to be relatively common
[31,39,40].  Co-infection can also occur in humans; a mixed
infection with HEV genotypes 3 and 4 was observed in a
patient with acute hepatitis E in Japan [51].
The phylogeny of the seven ORF2 sequences indicated
that three samples belonged to subtype 3c and four to the
subtype 3f. Lu and collaborators [2] suggested that the clas-
siﬁcation of a HEV strain tends to remain constant even
when different regions of the genome are analyzed. There-
fore, the detection of ORF1 and ORF2 sequences belonging
to different subtypes in pigs #034 and #035 supports the
hypothesis that these pigs were co-infected with multiple
subtypes, but we cannot rule out the existence of a recom-
binant virus.
The recombination event may  occur as a result of
co-infection or superinfection of the same host with
two or more strains [52]. The occurrence of inter- and
intra-genotype recombination among human and pig HEV
strains have been reported [52–54].  It is possible that
recombination can lead to the emergence of more viru-
lent variants of the virus, especially if it happens within
the capsid coding gene (ORF2) [53].
The presence of HEV infection in pigs at slaughter
age conﬁrms previous evidences that these animals may
be a source of infection not only for pig farm workers,
but also to slaughterhouse workers [43,55,56].  Moreover,
HEV infected pigs at slaughter age also represent a risk
of human infection by consumption of raw or under-
cooked meat from these animals [41,57–59].  For that
reason, the detection of HEV in pigs from Pará reinforces
the need for further studies to evaluate the pathogenic-
ity of these isolates and the risk factors for transmission
to humans, especially those that work on pig farms,
because the existence of a risk to public health cannot be
excluded.
In conclusion, the present study demonstrated the
presence of HEV infection in animals at slaughter age,
suggesting that pigs in the Eastern Brazilian Amazon are
exposed to HEV during different stages of their life cycle.
The epidemiological HEV dynamics in pig farms at this
region deserves additional studies. Herein, we reported the
ﬁrst identiﬁcation and genotyping of HEV in Eastern Brazil-
ian Amazon. The HEV subtypes circulating in pigs in the
Pará state were found to be related to human and ani-
mal  samples from other non-endemic regions of the world,
suggesting that these isolates had zoonotic potential. The
present investigation also detected the simultaneous pres-
ence of HEV subtypes 3c and 3f in some pigs, which suggests
that mixed infection by multiple and/or recombinant viral
strains occurs in these animals. Further studies should
be conducted to clarify the epidemiological signiﬁcance
of HEV circulating in the state of Pará and its impact on
public health in the Amazon region and in other Brazilian
regions.
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